New research suggests that sleep habits may influence how genetic variants affect early brain changes related to Alzheimer’s disease. Scientists at Edith Cowan University (ECU) found that sleep patterns could modify the effects of variants in the aquaporin-4 (AQP4) gene, which is involved in the brain’s fluid and waste clearance systems.
Read More
AQP4 plays a critical role in these waste removal processes, which are thought to become more active during sleep. This might help clear metabolic waste, including proteins associated with Alzheimer’s, although further research is needed to understand its impact on disease risk in humans.
Dr. Ayeisha Milligan Armstrong, one of the researchers, stated that individuals with certain AQP4 variants experienced faster gray matter loss when reporting shorter sleep durations. This indicates that how genes interact with environmental factors, such as sleep, is vital in understanding cognitive decline. “It’s not just which genes you carry; it’s how those genes interact with the world around you,” said Armstrong.
The study analyzed 13 common AQP4 variants, comparing them with participants’ self-reported sleep habits, brain scans, and cognitive performance. Results indicated varying effects of sleep patterns; for example, shorter sleep was linked to faster gray matter loss in some participants, while taking longer to fall asleep correlated with structural changes in others.
Dr. Tenielle Porter highlighted the variability among individuals, suggesting that poor sleep may affect Alzheimer’s-related changes differently depending on genetic profiles. This indicates that a personalized approach to Alzheimer’s prevention may be more effective than a one-size-fits-all methodology.
While the findings do not establish that sleep issues directly cause Alzheimer’s disease, they suggest that interventions could potentially be tailored to an individual's genetic makeup. The researchers advocate for genetically informed clinical trials to explore whether improving sleep could reduce risk in those with specific AQP4 variants.
Professor Simon Laws, director of ECU’s Centre for Precision Health, emphasized the need for precision health approaches in understanding why some individuals exhibit faster cognitive decline despite similar risk factors. The study's implications could pave the way for personalized lifestyle interventions for Alzheimer’s risk based on genetic predispositions.